|
8961 |
Safety, Tolerability and Pharmacokinetic and Pharmacodynamic Learnings from a Double-Blind, Randomized, Placebo-Controlled, Sequential Group First-in-Human Study of the TRPV1 Antagonist, JNJ-38893777, in Healthy Men
Enthalten in Clinical drug investigation Bd. 35, 17.4.2015, Nr. 6, date:6.2015: 353-363
|
|
|
|
8962 |
Safety, Tolerability and Pharmacokinetic-Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study
Enthalten in Neurology and Therapy Bd. 14, 21.12.2024, Nr. 1, date:2.2025: 357-377
|
|
|
|
8963 |
Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects
Enthalten in Clinical drug investigation Bd. 31, 24.8.2012, Nr. 5, date:5.2011: 325-335
|
|
|
|
8964 |
Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
Enthalten in Advances in therapy Bd. 40, 15.2.2023, Nr. 4, date:4.2023: 1628-1643
|
|
|
|
8965 |
Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects
Enthalten in Clinical drug investigation Bd. 30, 24.8.2012, Nr. 12, date:12.2010: 867-874
|
|
|
|
8966 |
Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study
Enthalten in European journal of drug metabolism and pharmacokinetics Bd. 47, 16.4.2022, Nr. 4, date:7.2022: 509-521
|
|
|
|
8967 |
Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
Enthalten in Advances in therapy Bd. 40, 26.5.2023, Nr. 7, date:7.2023: 3186-3198
|
|
|
|
8968 |
Safety, Tolerability, and Pharmacokinetics of Nebulized GB05-Human IFNα1b Inhalation Solution: A Randomized, Placebo-Controlled, Dose-Escalation Phase I Study in Healthy Chinese Adult Volunteers
Enthalten in Infectious diseases and therapy Bd. 13, 4.8.2024, Nr. 9, date:9.2024: 2053-2070
|
|
|
|
8969 |
Safety, Tolerability, and Pharmacokinetics of NRL-1049, a Rho-Associated Kinase Inhibitor, in Healthy Volunteers: A Phase 1, First-in-Human, Single-Ascending Dose, Randomized, Placebo-Controlled Trial
Enthalten in CNS drugs Bd. 39, 8.7.2025, Nr. 9, date:9.2025: 865-877
|
|
|
|
8970 |
Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
Enthalten in BMC pharmacology & toxicology Bd. 21, 6.1.2020, Nr. 1, date:12.2020: 1-10
|
|
Administration
